Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Here’s Why BIOLASE Shares Were Volatile This Week

BIOLASE Inc (NASDAQ: BIOL) shares are trading lower by 37% to $2.00 over the trailing five sessions after the company this week announced pricin
byHenry Khederian
September 15, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

BIOLASE Inc (NASDAQ:BIOL) shares are trading lower by 37% to $2.00 over the trailing five sessions after the company this week announced pricing of a $4.5 million underwritten public offering of Series J Convertible Redeemable Preferred Stock and warrants.

Before underwriting discounts and commissions and offering expenses, gross proceeds are expected to be approximately $4.5 million.

BIOLASE says the company intends to use the net proceeds from the offering for working capital and for general corporate purposes.

Lake Street Capital Markets, LLC and Maxim Group LLC are acting as joint bookrunners for the offering.

See Also: UAW Launches Historic Simultaneous Strike

According to data from Benzinga Pro, BIOL has a 52-week high of $338.00 and a 52-week low of $1.74.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Levi Strauss Likely To Report Sharp Drop In Q2 Earnings; Here’s A Look At Recent Price Target Changes By The Most Accurate Analysts

By Lisa Levin
July 5, 8:35 AM
Levi Strauss & Co. (NYSE: LECI) is expected to report its financial results for the second quarter ended May 28, 2023, after the closing bell on July 6, 2023. Analysts expect the company to post quarterly earnings at 3 cents per share, down from year-ago earnings of 23 cents per share. The company’s revenue might come in at $1.34 billion.

LECI